KRZYŽÁNKOVÁ, Miroslava, Silvia CHOVANOVÁ, Petr CHLAPEK, Matěj RÁDSETOULAL, Jakub NERADIL, Karel ZITTERBART, Jaroslav ŠTĚRBA and Renata VESELSKÁ. LOX/COX inhibitors enhance the antineoplastic effects of all-trans retinoic acid in osteosarcoma cell lines. Tumor Biology. Dordrecht: Springer, 2014, vol. 35, No 8, p. 7617-7627. ISSN 1010-4283. Available from: https://dx.doi.org/10.1007/s13277-014-2019-5.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name LOX/COX inhibitors enhance the antineoplastic effects of all-trans retinoic acid in osteosarcoma cell lines.
Authors KRZYŽÁNKOVÁ, Miroslava (703 Slovakia, belonging to the institution), Silvia CHOVANOVÁ (703 Slovakia, belonging to the institution), Petr CHLAPEK (203 Czech Republic, belonging to the institution), Matěj RÁDSETOULAL (203 Czech Republic, belonging to the institution), Jakub NERADIL (203 Czech Republic, belonging to the institution), Karel ZITTERBART (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution) and Renata VESELSKÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition Tumor Biology, Dordrecht, Springer, 2014, 1010-4283.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 40101 Agriculture
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.611
RIV identification code RIV/00216224:14310/14:00079005
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1007/s13277-014-2019-5
UT WoS 000341883500046
Keywords in English osteosarcoma; all-trans retinoic acid; caffeic acid; celecoxib; osteogenic differentiation
Tags AKR, rivok
Tags International impact, Reviewed
Changed by Changed by: prof. RNDr. Renata Veselská, Ph.D., M.Sc., učo 1260. Changed: 25/11/2015 22:14.
Abstract
In this study, the effects of combined treatment with all-trans retinoic acid (ATRA) and lipoxygenase/cyclooxygenase inhibitors were examined in two osteosarcoma cell lines, Saos-2 and OSA-01. Caffeic acid and celecoxib were used as inhibitors of 5-lipoxygenase and of cyclooxygenase-2, respectively. Changes in the cell proliferation, matrix mineralization, and occurrence of differentiation markers were evaluated in treated cell populations at intervals. The results confirmed the capability of caffeic acid to enhance the antiproliferative effect of ATRA in both cell lines. In contrast, celecoxib showed the same effect in Saos-2 cells only. Furthermore, the extension of matrix mineralization was observed after combined treatment with ATRA and celecoxib or caffeic acid. The increased expression of osteogenic differentiation markers was observed in both cell lines after the combined application of ATRA and inhibitors.
Links
EE2.3.20.0183, research and development projectName: Centrum experimentální biomedicíny
2SGA2834, interní kód MUName: Cellular and molecular responses induced by combined application of differentiating and antiangiogenic agents in sarcoma cell lines (Acronym: SARCOMBAT)
Investor: South-Moravian Region, Incoming grants
PrintDisplayed: 25/5/2024 19:24